Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Pluristem Therapeutics Inc.    PSTI   US72940R1023

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/15/2015 04/16/2015 04/17/2015 04/20/2015 04/21/2015 Date
2.92(c) 2.87(c) 2.81(c) 2.84(c) 2.82 Last
114 938 63 973 121 543 63 773 6 568 Volume
+1.39% -1.71% -2.09% +1.07% -0.70% Change
More quotes
Financials ($)
Sales 2015 0,47 M
EBIT 2015 -30,3 M
Net income 2015 -34,4 M
Debt 2015 -
Yield 2015 -
Sales 2016 15,3 M
EBIT 2016 -26,9 M
Net income 2016 -27,3 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 427x
Capi. / Sales 2016 13,2x
Capitalization 202 M
More Financials
Company
Pluristem Therapeutics, Inc. is a bio-therapeutic company, which develops standardized cell therapy products for the treatment of life threatening diseases.The company's patented PLX (PLacental eXpanded) cells drug delivery platform releases a cocktail of therapeutic proteins in response to a... 
More about the company
Surperformance© ratings of Pluristem Therapeutics Inc
Trading Rating : - Investor Rating :
More Ratings
Latest news on PLURISTEM THERAPEUTICS INC
04/20 PLURISTEM THERAPEUTICS : Clinical Advisory Board Prepares Phase II Clinical Tria..
04/20 PLURISTEM THERAPEUTICS : Clinical Advisory Board Prepares Phase II Clinical Tria..
03/25 PLURISTEM THERAPEUTICS : kündigt wichtige strategische Ziele für die Entwicklung..
03/24 PLURISTEM THERAPEUTICS : Regulation FD Disclosure, Financial Statements and Exhi..
03/24 PLURISTEM THERAPEUTICS : Announces Key Strategic Objectives for Development of P..
03/24 PLURISTEM THERAPEUTICS : Announces Key Strategic Objectives for Development of P..
03/24 Pluristem Announces Key Strategic Objectives for Development of PLX-R18 in He..
03/10 PLURISTEM THERAPEUTICS : to Present Data at Regenerative Medicine Conferences in..
More news
Sector news : Biotechnology & Medical Research - NEC
10:31a Juno Therapeutics' CAR T Cell Product Candidate JCAR017 Continues to Demonstr..
08:31a PHARMACYCLICS : Stock Updates on Biotech -- Celgene, Amgen, PDL BioPharma, Amari..
08:10aDJEuropean Stocks Steady as Robust Earnings Offset Greek Worries -- Update
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
04/09 WHY INVESTORS SHOULDN'T WORRY ABOUT : Maxim's Jason Kolbert
03/24 Pluristem details development plan for second cell product
02/17 PREMARKET GAINERS / LOSERS AS OF 9 : 10 am
02/12 NEOSTEM : The Levi Strauss Of Cell Therapy
02/11 German Researchers Verify Positive, System-Wide Effect Of Pluristem's PLX Cel..


Comments 
Advertisement
Chart PLURISTEM THERAPEUTICS INC
Duration : Period :
Pluristem Therapeutics Inc Technical Analysis Chart | PSTI | US72940R1023 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF